Integrated Kai Medical and Fobi Rapid Covid Testing System powers a return to in-person events
Gala Games is a blockchain gaming powerhouse, run by one of the founders of Zynga. Their Galaverse event is one of the largest events in Las Vegas, with live events held December 11th & 12th and a virtual event being held on the 13th. All of the live events were completely sold out, with over 30,000 people expected to attend, and a number of high-profile musical acts performed at the event, including Kings of Leon and Arcade Fire.
In order to keep the event safe, it was mandatory for all attendees to take a rapid Covid test performed by Kai Medical, and the results were delivered to users’ mobile phones by Fobi. The testing and results delivery process was very quick, taking approximately 10 minutes to do a self-test and then receive the results on their phone. If the results were negative, attendees were given a wristband that became their ticket to the event. The user experience for the testing was very good, registration was totally paperless with a scannable QR code, tables were spaciously separated to align with social distancing practices, and there were rigorous sanitizing processes in place.
Yoshi Tyler, Founder and President of Kai Medical said, “Returning to in-person events is an exciting step forward but doing so safely is of the utmost importance. I’m thrilled to see our team hit the ground running to provide Galaverse with a reliable, integrated testing system that streamlines the attendees experience.”
The Fobi Covid test results system was custom developed for this event, however it will be re-purposed for other events. It was also developed very quickly in just 2 days in response to a specific need from Kai Medical for this event, showcasing again the agility and innovation of Fobi’s development team. It also highlights the strength of the relationship between Fobi and Kai Medical, as well as Kai Medical’s parent company, Empower Clinics. This integration work will also work well for other use cases such as the Travel and Hospitality industries, which is particularly timely with the Cruise industry set to restart from Vancouver next spring.
Fobi CEO Rob Anson stated: “This was a great project for us to work on and delivered some great wins. Obviously, we helped support Kai Medical in delivering a huge event for Gala games, a pioneer in blockchain gaming, in Vegas, my second home. However, we’ve also developed a Covid Testing Results delivery system that integrates with our Wallet pass solution, and which we can deliver to other venues and events together with Kai Medical for integrated Covid testing and results delivery.”
About Kai Medical Laboratory
Kai Medical Laboratory is a high complexity laboratory accredited by Clinical Laboratory Improvement Amendments (CLIA) and Commission on Office Laboratory Accreditation (COLA). Our team consists of experienced scientists, medical professionals, and pharmacists. We provide reliable testing solutions to hospitals, medical clinics, pharmacies, and employer groups. Kai Medical Laboratory is focused on providing opportunities that change our current health system by improving the quality of life for employees and improving business results for client companies. We offer diversified services across the country to meet the current demands of today’s healthcare needs.
Fobi is a cutting-edge data intelligence company that helps our clients turn real-time data into actionable insights and personalized customer engagement to generate increased profits. Fobi’s unique IoT device has the ability to integrate seamlessly into existing infrastructure to enable data connectivity across online and on-premise platforms creating highly scalable solutions for our global clients. Fobi partners with some of the largest companies in the world to deliver best-in-class solutions and operates globally in the retail, telecom, sports & entertainment, casino gaming, and hospitality & tourism industries.
For more information, please contact:
Fobi AI Inc.
Fobi Website: www.fobi.ai
Rob Anson, CEO
Facebook: @ Fobiinc
T : +1 877-754-5336 Ext. 3
Twitter: @ Fobi_inc
LinkedIn: @ Fobiinc
This news release contains certain statements that constitute forward-looking statements or information, including statements regarding Fobi’s business and technology; the ability of Fobi to engage with industry participants to achieve its goals; the development of Fobi’s technology; and the viability of Fobi’s business model. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Fobi’s control, including the impact of general economic conditions, industry conditions, competition from other industry participants, stock market volatility, and the ability to access sufficient capital from internal and external sources. Although Fobi believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated, or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity, or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Fobi does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Fobi should be considered highly speculative. There can be no assurance that Fobi will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.